News By Tag
News By Place
Insight Pharma Reports Announces Biomarkers in Alzheimer’s Disease Report
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
Experts interviewed in this report include:
· Dr. Jens Wendland, Head of Neuroscience Genetics, Precision Medicine, PharmaTherapeutics, Pfizer Worldwide R&D
· Dr. Howard J. Federoff, Executive Vice President for Health Sciences, Georgetown University
· Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers
Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured in an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.
Insight Pharma Reports also put together a table of clinical trial information and pipeline data from multiple databases related to Alzheimer’s Disease. This table features companies, targets, clinical phases, and brief target/product descriptions.
For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/
or contact Kerri Kelley at email@example.com or 781-972-1347.
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/